Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Polyphenols, a diverse group of phytochemicals found in plants, have attracted scientific interest for their potential role in managing diabetic retinopathy (DR), a microvascular complication of diabetes. Experimental studies and some small clinical trials suggest that polyphenols—such as resveratrol (from grapes), curcumin (from turmeric), and epigallocatechin gallate (EGCG, from green tea)—may exert beneficial effects for diabetic retinopathy through antioxidant, anti-inflammatory, and anti-angiogenic mechanisms. These compounds have been shown in animal models and in vitro studies to reduce oxidative stress and inhibit pathways (such as VEGF signaling and NF-κB activation) that contribute to retinal damage in diabetes.

However, the bulk of the evidence remains preclinical or from small, early-phase human studies, often with variable results and methodological limitations. There is a lack of large, well-controlled human trials specifically demonstrating that generic or unspecified "polyphenol" supplementation meaningfully alters the course of diabetic retinopathy. Most guidelines do not recommend polyphenols as a standard therapy, and their use is not a mainstream medical practice for this indication. Thus, while scientific rationale and preliminary evidence exist, the overall strength of evidence supporting polyphenols (unspecified) for diabetic retinopathy is currently weak to moderate.

More about Polyphenol (unspecified)
More about Diabetic Retinopathy

Other ingredients used for Diabetic Retinopathy

Other health conditions supported by Polyphenol (unspecified)

Products containing Polyphenol (unspecified)